APA (7th ed.) Citation

Jung, J., Lee, J. H., Kim, S., Lee, J. H., Yoo, K. H., Do, Y. R., . . . Yi, J. H. (2026). Second Salvage Autologous Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Multiple Myeloma in the Era of Novel Agents: Results of the KMM2301 Study. Cancers, 18(3), 471. https://doi.org/10.3390/cancers18030471

Chicago Style (17th ed.) Citation

Jung, Jongheon, et al. "Second Salvage Autologous Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Multiple Myeloma in the Era of Novel Agents: Results of the KMM2301 Study." Cancers 18, no. 3 (2026): 471. https://doi.org/10.3390/cancers18030471.

MLA (9th ed.) Citation

Jung, Jongheon, et al. "Second Salvage Autologous Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Multiple Myeloma in the Era of Novel Agents: Results of the KMM2301 Study." Cancers, vol. 18, no. 3, 2026, p. 471, https://doi.org/10.3390/cancers18030471.